Roche, Protein Design to Develop Drug
241106
Hoffman-La Roche Inc., the US prescription pharmaceuticals unit of Swiss drug maker Roche Group, said Thursday that it will jointly develop and market an asthma drug with biotechnology firm Protein Design Labs Inc.
495115
Researchers say targeting a protein may overcome the malaria parasite's increasing resistance to drugs.
12943
Systems biologists are pushing the envelope of preventive medicine through research centered on the interactions of the thousands of pieces of DNA, RNA and proteins that network together in each cell of our body. By Rowan Hooper.
578661
Basel, Switzerland, November 30 (ots/PRNewswire) - Roche and Genentech, Inc., announced today that Avastin(TM) (bevacizumab, rhuMAb-VEGF), a new innovative anti-angiogenesis drug, has shown for the first time that it significantly increases survival in
329842
Serono is teaming up with  California-based biotech firm CancerVax Corp. to develop a new  skin cancer drug, as Europe's biggest biotech firm aims to  strengthen its pipeline by moving into cancer treatment.
709547
Swiss drugmaker Roche&#39;s (ROG.VX: Quote, Profile, Research) majority-owned biotech firm Genentech Inc (DNA.N: Quote, Profile, Research) faces an investigation by US
15160
The Swiss pharmaceutical company Roche Holding said its chief executive would step down next March as the company separates that job from the chairmanâs position. Franz B. Humer, who has been chief since 1998, will remain chairman of the board. Next July, he also will become chairman of the beverage company Diageo. He will be succeeded by Severin Schwan, 40, who had been the head of Rocheâs diagnostics unit since January. The company also posted a 24 percent increase in first-half net profit, to 4.92 billion Swiss francs ($4.1 billion) from 3.97 billion francs in the period a year earlier. Roche benefited from its flu treatment Tamiflu as governments stockpile the drug in case of an influenza pandemic.
593100
BioMarin files a marketing application for its lead compound in development.
664016
âWe show, for the first time, we can deliver these potentially high-quality therapeutics to an animal.â Hans-Peter Vornlocher, Scientist, Alnylam Pharmaceuticals.
428251
Targeting a key protein may help overcome the malaria parasite's increasing resistance to existing drugs, UK researchers say.
634377
Researchers have discovered that malignant melanoma, the potentially lethal skin cancer, can&#39;t grow without a steady supply of a protein that normal cells can do without.
755242
Swiss drug maker Roche Holding AG said Friday that it is moving to provide smaller child-sized capsules of Tamiflu, the medicine many governments have been stockpiling as an initial defense against a pandemic that might result from the bird flu virus.
351992
In the latest endorsement of a science technique discovered at the University of Massachusetts, the international drug giant Roche signed a $331 million deal with Alnylam Pharmaceuticals Inc. of Cambridge for the rights to develop drugs using RNA interference.
727152
New developments are brewing at the pharmaceutical.
320439
Scientists have shown that a single protein plays a central role in the development of diabetes.
260486
A team of Finnish researchers has developed a drug that could be a major advancement in treating degenerative diseases, including Alzheimer's. The team, working with Tampa's Johnnie B. Byrd Sr.
519863
The company faces a pivotal clinical trial.